Second malignancies after chemotherapy and transplantation.
Gertz
M A
MA
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN 55905.
Noël
P
P
Kyle
R A
RA
D000477:Alkylating Agents / Q000009:adverse effects*; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D008232:Lymphoproliferative Disorders / Q000209:etiology; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000209:etiology / Q000235:genetics / Q000628:therapy; D016377:Organ Transplantation / Q000009:adverse effects*
D000477:Alkylating Agents